Morgan Stanley Maintains Equal-Weight on Innovid, Raises Price Target to $1.5
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Brian Nowak maintains an Equal-Weight rating on Innovid (NYSE:CTV) and raises the price target from $1.4 to $1.5.
November 09, 2023 | 2:13 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Morgan Stanley maintains an Equal-Weight rating on Innovid and raises the price target from $1.4 to $1.5. This could potentially lead to a positive sentiment among investors.
The raised price target by Morgan Stanley indicates a positive outlook for Innovid. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100